Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | MMP9 | P14780 | 1/20 | 0.59 |
| ▸ | MMP8 | P22894 | 1/20 | 0.59 |
| ▸ | MMP13 | P45452 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tosylchloramide SCHEMBL14764471 | 1.00 | GAA (0.61) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL28882248 | 1.00 | GAA (0.61) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL14764474 | 1.00 | GAA (0.61) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL10526373 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL696560 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL6009520 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL8154955 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL3615720 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL7225596 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 | |
| Tosylchloramide SCHEMBL10424726 | 0.98 | GAA (0.59) | GAASMN1; SMN2CA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 846 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874514-A | Synthesis method of fluoroquinolone drug intermediate | 帕潘纳(北京)科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| EP-4458343-A1 | DEVICE FOR PREPARING AND DISPENSING ACTIVE AGENT SOLUTIONS | Heraeus Medical GmbH (DE) | 2024-11-06 | — | — | EP | claimed |
| CN-118892416-A | Device for preparing and dispensing solutions of active ingredients | 贺利氏医疗有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-114166921-B | Application of chloramine derivatization reagent in double bond position identification | 中国科学院上海有机化学研究所 | 2024-04-26 | — | — | CN | claimed |
| US-11827584-B2 | Process for preparing cyanoacetates | HENKEL AG & CO. KGAA (DE) | 2023-11-28 | — | — | US | claimed |
| EP-4229098-A1 | CONTROLLED RELEASE OF GLYCANS FROM GLYCOPROTEINS AND ENVELOPED VIRUSES | Hochschule für Technik und Wirtschaft (HTW) Berlin (DE) | 2023-08-23 | — | — | EP | claimed |
| EP-4121220-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | Molecular Plasma Group SA (LU) | 2023-01-25 | — | — | EP | claimed |
| WO-2022078612-A1 | CONTROLLED RELEASE OF GLYCANS FROM GLYCOPROTEINS AND ENVELOPED VIRUSES | HOCHSCHULE FÜR TECHNIK UND WIRTSCHAFT (HTW) BERLIN (DE) | 2022-04-21 | — | — | WO | claimed |
| CN-114166921-A | Application of chloramine derivatization reagent in identifying position of double bond | 中国科学院上海有机化学研究所 | 2022-03-11 | — | — | CN | claimed |
| EP-3956297-A1 | PROCESS FOR PREPARING CYANOACETATES | Henkel IP & Holding GmbH (DE) | 2022-02-23 | — | — | EP | claimed |
| EP-0269729-A1 | METHOD OF PREPARING TOXOID. | SEKURA RONALD D | 1988-06-08 | — | — | EP | claimed |
| US-4729948-A | STARCH-IODINE COMPLEX | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1988-03-08 | — | — | US | claimed |
| US-4729845-A | STORAGE STABLE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1988-03-08 | — | — | US | claimed |
| CN-87104279-A | Novel method for preparing toxoid | — | 1988-01-20 | — | — | CN | claimed |
| WO-1987007507-A1 | METHOD OF PREPARING TOXOID | SEKURA RONALD D (US) | 1987-12-17 | — | — | WO | claimed |
| US-4690770-A | MIXTURE OF SODIUM METASILICATE, PENTASODIUMTRIPHOSPHATES AND CHLORINE DONOR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-09-01 | — | — | US | claimed |
| US-4681696-A | SULFONAMIDE STABILIZERS | CHEMED CORPORATION (US) | 1987-07-21 | — | — | US | claimed |
| EP-0165676-A2 | Stabilized active halogen-containing detergent compositions and methods | CHEMED CORPORATION (US) | 1985-12-27 | — | — | EP | claimed |
| US-4132768-A | IODOFORM REACTION WITH RADIOACTIVE IODINE, MEDIACL DIAGNOSIS | Ui, Michio (JP) | 1979-01-02 | — | — | US | claimed |
| US-4107176-A | SILVER HALIDE COMPLEXING AGENTS | POLAROID CORPORATION (US) | 1978-08-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827584-B2 | Process for preparing cyanoacetates | PCCA, DNPEP, ASNS | GAA 536/4885SMN1; SMN2 4106/4885CA1 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.